Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives
Pharmaceutics · 29.06.2023 · 15 (7) · 1849
DOI: 10.3390/pharmaceutics15071849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.06.2023. Verfasst von Maria Karayianni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave., 11635 Athens, Greece. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chitosan is a naturally occurring polymer derived from the deacetylation of chitin, which is an abundant carbohydrate found mainly in the shells of various marine and terrestrial (micro)organisms. Chitosan has been extensively used to construct nanoparticles (NPs), which are biocompatible, biodegradable, non-toxic, easy to prepare, and can function as effective drug delivery systems. Moreover, chitosan NPs have been employed in gene and vaccine delivery, as well as advanced cancer therapy, and they can also serve as new therapeutic tools against viral infections. In this review, we summarize the most recent developments in the field of chitosan-based NPs intended as nucleic acid delivery vehicles and gene therapy vectors. Special attention is given to the technological aspects of chitosan complexes for nucleic acid delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave., 11635 Athens, Greece.
- Centre of Polymer and Carbon Materials, Polish Academy of Sciences, 34, M. Curie-Sklodowska St., 41-819 Zabrze, Poland.
- Section of Pharmaceutical Technology, Faculty of Pharmacy, Panepistimioupolis Zografou, National and Kapodistrian University of Athens, 15771 Athens, Greece.
ORCID-Profile: Maria Karayianni, Theodore Sentoukas, Athanasios Skandalis, Stergios Pispas
Zitieren
APA
Karayianni, M., Sentoukas, T., Skandalis, A., Pippa, N., & Pispas, S. (2023). Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives. Pharmaceutics, 15(7), 1849. https://doi.org/10.3390/pharmaceutics15071849
Vancouver
Karayianni M, Sentoukas T, Skandalis A, Pippa N, Pispas S. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives. Pharmaceutics. 2023;15(7):1849. doi:10.3390/pharmaceutics15071849
BibTeX
@article{Karayianni2023,
author = {Karayianni, Maria and Sentoukas, Theodore and Skandalis, Athanasios and Pippa, Natassa and Pispas, Stergios},
title = {Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {7},
pages = {1849},
doi = {10.3390/pharmaceutics15071849}
}
EUVIMED